Cross-Sector entity
IANS is most often covered alongside Active Pharmaceutical Ingredients, which appears in 1 of these 2 stories. Across a 41-day span, the pace is roughly 0.3 stories per week. The clearest coverage concentration is disruptions: 1 of 2 stories, with the rest divided among 1 other category.
2 verified stories tracked
Last mentioned: Sep 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
IANS is most often covered alongside Active Pharmaceutical Ingredients, which appears in 1 of these 2 stories. Across a 41-day span, the pace is roughly 0.3 stories per week. The clearest coverage concentration is disruptions: 1 of 2 stories, with the rest divided among 1 other category. Each carries 2 original sources on average. This profile follows 2 Cross-Sector stories mentioning IANS across the period from August 3, 2026 to September 12, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering IANS. Shared-story counts are live from our verified record — not editorial picks.
A new report urges the EU to copy the UK's playbook for decoupling critical supply chains from China by shifting electronics, solar components, pharmaceuticals, and rare earths sourcing toward India. Procurement and manufacturing leaders should note the call for a phased, sector-by-sector transition rather than an abrupt switch.
Source: ianslive.in · prokerala.com
Congressman Suhas Subramanyam says H-1B holders start companies that employ Americans, countering claims of job theft. For HR leaders, this underscores the program's role in filling critical talent gaps, while looming reforms could reshape compliance and global hiring.
Source: newkerala.com · prokerala.com
